About Careers Internship MedBlog Contact us

Drug to Eliminate Chikungunya and Yellow Fever Viruses

by Ramya Rachamanti on December 19, 2018 at 2:00 PM
Drug to Eliminate Chikungunya and Yellow Fever Viruses

Sofosbuvir, the drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus, according to a study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil.

"Human cells infected by chikungunya virus were treated with sofosbuvir, and the drug eliminated the virus without damaging any cells. The drug proved to be 11 times more effective against the virus than against cells," said Rafaela Milan Bonotto, a coauthor of the study.


The study relating to chikungunya was conducted as part of Bonotto's PhD research with a scholarship from São Paulo Research Foundation - FAPESP and supervision by Professor Lucio Freitas-Junior.

An article on the study, signed by Bonotto, Freitas-Junior and collaborators, can be found on the open platform F1000 Research. An article on the group's research relating to yellow fever will be published shortly.

The discovery is highly significant for public health, as a chikungunya epidemic has been forecast for the coming two years in Brazil.

"Drug development is extremely costly and time-consuming. The process takes 12 years on average between the start of research and bringing the drug to market. The cost is on the order of US$1.5 billion or more," Freitas-Junior said.

"Sofosbuvir has been fully approved for human use. This means it can be readied for use against chikungunya in one to three years, for a much lower cost, estimated at approximately US$500,000.

"He noted that chikungunya is a severe disease not only owing to the acute episode itself - causing symptoms similar to those of dengue - but because it can cause complications that include highly debilitating joint pain lasting months or years. The patient may become incapacitated, unable to work and even bedridden.

"So far we have no vaccine, and our diagnostic tools need to be optimized," he continued. "Sofosbuvir is something concrete that could become a powerful weapon against this virus. The results of our research could enable any interested institutions to begin clinical trials." Bonotto said, "We don't yet know exactly how the drug works in molecular terms. What we discovered was the macroscopic result: elimination of the virus and preservation of cells. The drug has proven effective in treating hepatitis C because it inhibits the protein that synthesizes the viral genome. The same may happen in the case of chikungunya, but the action mechanism must be elucidated."

The study supported by FAPESP was conducted on the Phenotypic Screening Platform (PSP), a new initiative of ICB-USP's Microbiology Department. Phenotypic screening assays have been successfully used to discover drugs with new action mechanisms.

The PSP has a portfolio of over 15 different types of phenotypic screening assays performed in accordance with the standards accepted by the pharmaceutical industry. The assays have been used as part of a strategy to reposition drugs for infectious diseases.

Four other researchers took part in the study in addition to Bonotto and Freitas-Junior: Glaucia Souza-Almeida, Soraya Jabur Badra, Luiz Tadeu Figueiredo and Carolina Borsoi Moraes.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Drug News

Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Drug to Eliminate Chikungunya and Yellow Fever Viruses Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests